Owlstone Medical partners with Shanghai Renji Hospital

China |  News | 0 Comment | 22 Feb, 2019

Owlstone Medical, a diagnostics company developing a breathalyzer for applications in early disease detection and precision medicine, and Renji Hospital has announced a collaboration to con...Read more

HaiHe Biopharma, CSPC form a JV to co-develop innovative drugs

China |  News | 0 Comment | 22 Feb, 2019

Shanghai based HaiHe Biopharma , which focuses on the discovery, development and commercialization of innovative drugs for cancer, and China's famous pharmaceutical group, China Shijiazhuan...Read more

HLT, PPD collaborate to enhance drug development

China |  News | 0 Comment | 21 Feb, 2019

Pharmaceutical Product Development, LLC (PPD) and Happy Life Tech (HLT) of China have signed an exclusive agreement to develop a distinctive service offering for the China drug-development ...Read more

Medical Insurance for basic services at SCMCC

China |  News | 0 Comment | 21 Feb, 2019

Concord Medical Services Holdings Limited, a leading specialty hospital management solution provider and operator of a network of radiotherapy and diagnostic imaging centres in China, has a...Read more

YITU Healthcare publishes major AI breakthrough

China |  News | 0 Comment | 20 Feb, 2019

YITU Healthcare has successfully used natural language processing (NLP) to achieve high accuracy rates on par with doctors when reading electronic health records and generating patient diag...Read more

WuXi STA signs exclusive technology and marketing partnership with BioLingus

China |  News | 0 Comment | 19 Feb, 2019

STA Pharmaceutical Co., Ltd., (WuXi STA), a subsidiary of WuXi AppTec, and BioLingus, a Swiss biotech company, have formed an exclusive technology and marketing collaboration for ...Read more

EMA completes inspection of cGMP DS and DP facilities at WuXi Biologics

China |  News | 0 Comment | 19 Feb, 2019

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that the E...Read more

Chipscreen Biosciences unites with Innovent for colorectal cancer therapy

China |  News | 0 Comment | 18 Feb, 2019

Chipscreen Biosciences, a leading integrated Chinese biotech company specialized in discovery and development of novel small molecule pharmaceuticals with a primary focus in oncology, metab...Read more

Cigna brings Medical Plan on OneDegree Global's Online Platform

China |  News | 0 Comment | 18 Feb, 2019

Cigna Corporation's Hong Kong business has announced that its Cigna Plus Medical Plan health insurance product is now available on the new digital platform powered by On...Read more

Burning Rock completes Series C financing of RMB 850M

China |  News | 0 Comment | 15 Feb, 2019

Burning Rock recently held the signing ceremony and announced the closing of the Series C financing totaling RMB 850 million. The financing was led by GIC, followed by LYFE Capital, CMB Int...Read more

Innovent announces first patient dosing of IBI 101 study

China |  News | 0 Comment | 15 Feb, 2019

Innovent Biologics, Inc. (Innovent) , a world-class biopharmaceutical company that develops, manufactures and commercializes high quality innovative medicines for the treatment of oncology,...Read more

Ascletis, 3-V Biosciences ink strategic license agreement for NASH drug

China |  News | 0 Comment | 14 Feb, 2019

Ascletis Pharma through its subsidiary, and 3-V Biosciences have entered into an exclusive license agreement for 3-V Biosciences' FASN (fatty acid synthase) inhibitor TVB-2640 (Ascletis cod...Read more

3SBio and Verseau team up for Immuno-Oncology Therapies

China |  News | 0 Comment | 13 Feb, 2019

3SBio and Verseau Therapeutics have announced a partnership agreement focused on the development and commercialization of novel monoclonal antibodies in the field of immuno-oncology for a b...Read more

WuXi Biologics enters into commercial manufacturing partnership with Amicus

China |  News | 0 Comment | 13 Feb, 2019

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Amicus Therapeut...Read more

Samsung Bioepis, C-Bridge Capital to develop next-gen biosimilars

China |  News | 0 Comment | 12 Feb, 2019

Samsung Bioepis Co., Ltd. has announced its expansion in mainland China through a licensing agreement with C-Bridge Capital. The agreement covers multiple biosimilar candidates from Samsung...Read more

Female contraceptive market set to be worth $8.7bn by 2027

China |  News | 0 Comment | 11 Feb, 2019

Contraceptive market sales were estimated to be $6.3bn across the 8MM (US, France, Germany, Italy, Spain, UK, Japan and China) in 2017, which is expected to grow to $8.2bn in 2027, at ...Read more

Lunar New Year focuses on traditional chinese medicine for cancer treatment

China |  Opinion | 0 Comment | 09 Feb, 2019

The Lunar New Year welcomes a focus on the wellbeing of the entire body leading to renewed discussions about the benefits of traditional Chinese medicine (TCM).   The popularity of TC...Read more

CStone, IMPACT Therapeutics’ anti-tumor therapy gets IND filing acceptance

China |  News | 0 Comment | 08 Feb, 2019

CStone Pharmaceutical and IMPACT Therapeutics, Inc. have jointly announced that an Investigational New Drug (IND) filing has been accepted by the National Medical Products Administration (N...Read more